0.9% Sodium Chloride (NaCl)

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, MassBiologics

Conditions

AnesthesiaDiphtheriaLyme DiseaseNeuromuscular Blockade

Phase 1

Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects

CompletedNCT04075175

MassBiologicsDiphtheria

Start: 2019-04-23End: 2019-10-07Updated: 2020-02-05

First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People

CompletedNCT04863287

MassBiologicsLyme Disease

Start: 2021-02-11End: 2022-08-16Updated: 2022-09-16

Phase 3

Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)

CompletedNCT00758485

Merck Sharp & Dohme LLCAnesthesia, Neuromuscular Blockade

Start: 2008-10-31End: 2009-06-30Updated: 2015-08-21

Related Papers

A Phase 1 Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of a Human Monoclonal Antibody (S315) Against Diphtheria Toxin.

2025-09-012 citations